Menů dei Marcatori

Ipertesto Neoplasie

 

LINKS

 

 

   

  CD15

REFERENCES

1. Swerdlow SH, eta al. A spectrum of Leu M1 staining in lymphoid and hemopoietic proliferations. Am J Clin Pathol 1986, 85:283-288

2. Crocker J, et al. Presence of 3-fucosyl-N-acetyllactosamine shown by monoclonal antibody AGF 4.48 in Reed-Sternberg cells. J Clin Pathol 1986, 39:564-8

3. Stein H, et al. Reed-Sternberg and Hodgkin's cells in lymphocyte-predominant Hodgkin's disease of nodular subtype containing J chain. Am J Clin Pathol 1986, 86:292-297

4. von Wasielewski R, et al. The nodular lymphocyte predominance type is characterised by negative neoplastic cells. Am J Pathol 1997, 150:793-803

5. von Wasielewski R, et. al.  Classical Hodgkin's disease. Clinical impact of the immunophenotype. Am J Pathol 1997, 151:1123-30

6. Rosso R, et al. Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Immunohistochemical and morphological relationships to Hodgkin's disease. Virchows Arch A Pathol Anat Histopathol 1990;416:229-35

7. Mori N, et al. Hodgkin disease with subsequent transformation to CD30 positive non-hodgkin lymphoma in six patients. Cancer 1999, 15;85:970-9.

8. Chilosi M, Doglioni C, Menestrina F, Montagna L, Rigo A, Lestani M, Barbareschi M, Scarpa A, Mariuzzi GM, Pizzolo G. Abnormal expression of the p53-binding protein mdm2 in Hodgkin's disease. Blood 1994, 84:4295-4300

9. Combs SG, et al.Immunohistochemical localization of the immunodominant differentiation antigen lacto-N-fucopentaose III in normal adult and fetal tissues. J Histochem Cytochem 1984, 32:982-988

10. Sewell HF, et al. Reaction of monoclonal anti LeuM1 – a myelomonocytic marker (CD15) – with normal and neoplastic epithelia. J Pathol 1987, 151:279-284.

11. Sheibani K, et al. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of LeuM1 antigen. Am J Pathol 1986; 123:212-219

12. Doglioni C, et al.Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996 Sep;20(9):1037-46

13. Ordonez NG. The immunohistochemical diagnosis of epithelial mesothelioma. Hum Pathol 1999,30:313-23

14. Kadota A, et al. Evaluation of expression of CD15 and sCD15 in non-small cell lung cancer.  Int J Oncol 1999,15:1081-9

15. Arber DA, and Weiss LM. CD15: a review. Appl Immunohistochem 1: 17-30, 1993

Menů  CD15